Mixed Covid-19 Vaccine Studies Begin, Putting More Americans at Risk

Mixed Covid-19 Vaccine Studies Begin, Putting More Americans at Risk


With vaccine hesitancy on the rise, Covid vaccine makers are pushing forward with clinical trials on adults. 

The most recent studies to begin are trials of the vaccinated receiving a different vaccine booster shot around 3-4 months later.

Fauci initially said those taking the vaccine would need a booster shot at some point, so it should come as no surprise more Covid vaccine studies are underway. 

Trending: WATCH: Arizona Audit Hand Count COMPLETED

The National Institutes of Health (NIH)  made this announcement on June 1st.

News: NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins https://t.co/5eJRfFQnVK

— NIH (@NIH) June 1, 2021

Right now, three Covid vaccines are authorized in America: Johnson & Johnson, Pfizer-BioNTech, and Moderna.

Apparently, the study will determine the safety and immunogenicity of mixed boosted regimens against Covid. 

Here is more about the new clinical trials from the NIH website:

The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been

Continue reading

You Might Like

Daily Truth Report • DailyTruthReport.com
Thanks for sharing!
Send this to a friend